Precigen, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 16:00:00 2026-07-07 EDT			5-day change	1st Jan Change
5.510 ^USD	-1.61%		-3.33%	+31.82%

07-02	Precigen Insider Sold Shares Worth $1,113,143, According to a Recent SEC Filing	MT
07-02	Precigen Insider Sold Shares Worth $2,042,864, According to a Recent SEC Filing	MT

Published on 03/31/2026 at 01:05 pm EDT - Modified on 04/01/2026 at 01:21 am EDT

S&P Capital IQ

Presenter Speech
Swayampakula Ramakanth (Analysts)

Good morning. I'm RK, a senior sell-side biotech analyst at H.C. Wainwright. So -- and we are thrilled to be hosting Precigen for this fireside chat

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

07-02	Precigen Insider Sold Shares Worth $1,113,143, According to a Recent SEC Filing	MT
07-02	Precigen Insider Sold Shares Worth $2,042,864, According to a Recent SEC Filing	MT
06-29	Precigen, Inc.(NasdaqGS:PGEN) dropped from Russell 2000 Value Benchmark	CI
06-29	Precigen, Inc.(NasdaqGS:PGEN) dropped from Russell Microcap Value Benchmark Index	CI
06-28	Precigen, Inc.(NasdaqGS:PGEN) dropped from Russell 3000E Value Benchmark	CI
06-28	Precigen, Inc.(NasdaqGS:PGEN) dropped from Russell 3000 Value Benchmark	CI
06-28	Precigen, Inc.(NasdaqGS:PGEN) dropped from Russell Small Cap Comp Value Benchmark	CI
06-28	Precigen, Inc.(NasdaqGS:PGEN) dropped from Russell 2500 Value Benchmark	CI
06-15	Precigen Wins FDA Orphan Drug Exclusivity for Airway Disease Treatment	MT
06-08	Precigen, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-08-2026 09:20 AM
05-30	Precigen Presents New Long-Term Durability Data for Papzimeos and Receives Seven-Year Market Exclusivity	CI
05-13	Precigen, Inc., Q1 2026 Earnings Call, May 13, 2026
05-13	Precigen, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-13	Precigen Q1 Loss Narrows, Revenue Rises	MT
05-13	Earnings Flash (PGEN) Precigen Posts Q1 Per Share Loss $0.02, vs. FactSet Est of $0.02 Loss	MT